0001179110-20-001412.txt : 20200210 0001179110-20-001412.hdr.sgml : 20200210 20200210192224 ACCESSION NUMBER: 0001179110-20-001412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200207 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Paul A. CENTRAL INDEX KEY: 0001565541 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 20593399 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 4 1 edgar.xml FORM 4 - X0306 4 2020-02-07 0 0000896264 USANA HEALTH SCIENCES INC USNA 0001565541 Jones Paul A. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120 0 1 0 0 Chief Leadership Dev Officer Common Stock 2020-02-07 4 M 0 3635 70.745 A 8669 D Common Stock 2020-02-07 4 S 0 3635 80.50 D 5034 D Common Stock 2020-02-07 4 M 0 533 70.745 A 5567 D Common Stock 2020-02-07 4 S 0 533 81.00 D 5034 D Common Stock 2020-02-10 4 M 0 3265 70.745 A 8299 D Common Stock 2020-02-10 4 S 0 3265 81.00 D 5034 D Stock - Settles Stock Appreciation Right 70.745 2020-02-07 4 M 0 30000 0 D 2018-09-01 2020-03-01 Common Stock 30000 30000 D Stock - Settles Stock Appreciation Right 70.745 2020-02-07 4 M 0 4210 0 D 2019-09-01 2020-03-01 Common Stock 4210 25790 D Stock - Settles Stock Appreciation Right 70.745 2020-02-10 4 M 0 25790 0 D 2019-09-01 2020-03-01 Common Stock 25790 0 D The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Josh Foukas, as attorney in fact. 2020-02-10